The market is segmented based on , By Type (Diagnosis, Therapeutics), Product (Reagents, Assay, Instruments, Software), Technology (Microbiology, PCR, Sequencing, Biomarkers), Test Type (Lab, POC), Pathogen (Bacterial, Viral, Fungal), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Pathology and Reference Laboratories), Application (Sepsis, Severe Sepsis, Septic Shock) – Industry Trends and Forecast to 2029
.
The Global Sepsis Market size was valued at USD 1.07 USD Billion in 2023.
The Global Sepsis Market is projected to grow at a CAGR of 8.5% during the forecast period of 2024 to 2031.
The major players operating in the market include bioMé,rieux , BD , Danaher , Biosystems Inc. Luminex Corporation , F. Hoffmann-La Roche Ltd. Thermo Fisher Scientific Inc. Bruker , Abbott , Immunexpress Inc. , Axis-Shield Diagnostics Ltd. UK), Quidel Corporation , Siemens , EKF Diagnostics , Seegene Inc. Boditech Med Inc. and Alifax S.r.l.Italy ,.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.